The First International Symposium on Kallikreins
A comprehensive nomenclature for serine proteases with homology to tissue kallikreins
The kallikrein world
Cellular distribution of human tissue kallikreins
The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction
Proteinase-mediated cell signalling
Recombinant kallikrein expression
Kallikrein-related peptidase (KLK) family mRNA variants and protein isoforms in hormone-related cancers
The role of kallikrein-related peptidases in prostate cancer
Human kallikrein 10, a predictive marker for breast cancer
Activation and enzymatic characterization of recombinant human kallikrein 8
Human tissue kallikrein 9
The human kallikrein 10 promoter contains a functional retinoid response element
Human kallikrein 4
Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum
A sensitive proximity ligation assay for active PSA
Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer
Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues
mRNA expression analysis of human kallikrein 11 (KLK11) may be useful in the discrimination of benign prostatic hyperplasia from prostate cancer after needle prostate biopsy
The epigenetic basis for the aberrant expression of kallikreins in human cancers
Improved prostate cancer detection with a human kallikrein 11 and percentage free PSA-based artificial neural network
Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells
Inhibition profiles of human tissue kallikreins by serine protease inhibitors
Kallikrein-mediated cell signalling